Under the trend of centralized drug procurement, take the "last mile" of patient medication

Centralized procurement of drugs by volume is an important measure for the reform of the supply side of medical services.

In order to help medical institutions in China continue to strengthen their clinical drug application management capabilities, establish a patient-centered clinical drug management model, and promote the exploration of rational drug use, from August 2020 to July 2021, "Policy interpretation and experience sharing of centralized drug procurement and use "Seminars" were successively held in six provinces (regions) of Shaanxi, Guangxi, Xinjiang, Hainan, Qinghai and Guizhou

Reduce the cost of medication and help the development of the pharmaceutical industry

The issue of drug prices is a hot issue in the field of medicine in China, and it is also a livelihood issue that the people are most concerned about

The data shows that the average price cut of the products selected in the first three batches of national organization of centralized drug procurement reached 54%

In addition, Jiang Changsong also pointed out that since the medical insurance fund also supports the innovative development of medicines, medical devices, and clinical technology, centralized drug procurement can improve the efficiency of the medical insurance fund and provide high-quality innovative development for the pharmaceutical industry.

Reasonably use selected drugs to meet the needs of patients

On January 28, the General Office of the State Council issued the "Opinions on Promoting the Normalized and Institutionalized Development of Centralized and Volumetric Procurement of Pharmaceuticals".

After the drugs are admitted to the hospital, how can doctors take the initiative to choose drugs selected from centralized procurement, and how to let patients dispel their worries and use the drugs selected from centralized procurement with confidence? Zhang Jingyi, director of the clinical pharmacy department of the General Hospital of the Northern War Zone, believes that on the one hand, it is necessary to strengthen policy publicity and outpatient services for patients Guidance, on the other hand, we must strengthen the training and guidance of doctors

Regarding the clinical use of centralized procurement of drugs, Zhang Yong, deputy director of the Medical Price and Bidding Purchasing Department of Qinghai Medical Insurance Bureau, pointed out that some medical institutions have a "one size fits all" error in management, and only select drugs selected for mass procurement

Improve management level and attach importance to clinical use monitoring

Yang Zhao, an associate researcher at the Public Policy Research Center of Peking University, pointed out that with the normalization and institutionalization of volume-based procurement policies, medical institutions should gradually improve their medication standards

Shen Jing, director of the Pharmacy Department of the Fifth Affiliated Hospital of Xinjiang Medical University, shared his experience in monitoring the use of selected drugs in centralized procurement

"The local medical insurance department can set up some topics for the quality evaluation of the selected varieties, and then invite the local hospitals to do the corresponding research.